Ledger.Open graph →
SEC Form D · filed May 14, 2019

Regulus Therapeutics Inc

Offering
$79.3M
Sold
$16.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Stelios R. Papadopoulos · San Diego, CADirectorPascale H. Witz · San Diego, CADirectorJoseph P. Hagan · San Diego, CAExec · DirectorKathryn J. Collier · San Diego, CADirectorHugh H. Rosen · San Diego, CADirectorChristopher R. Aker · San Diego, CAExecDavid R. Baltimore · San Diego, CADirectorWilliam H. Rastetter · San Diego, CADirectorDaniel R. Chevallard · San Diego, CAExecJeffrey Semple · Blacklick, OHExec · DirectorJeremiah O'Brien · TURNERSVILLE, NJDirectorAnthony Susco · TURNERSVILLE, NJDirectorMichael Derringer · Blacklick, OHDirectorJames Gilbride · Blacklick, OHDirectorDavid Tramontana · Blacklick, OHExecPeter Christiansen · TURNERSVILLE, NJDirectorClive Harris · George Town, Cayman IslandsDirectorGraeme J. Dell · St. Peter Port, Y7Exec · DirectorLaurence S. Mcnaim · St. Peter Port, Y7ExecKamyar Khajavi · New York, NYDirectorMichael M. Konson · Reston, VADirectorLauren F. Mckelvey · Reston, VADirectorDavid M. Wasik · Reston, VADirectorJohn M. Fruehwirth · Reston, VADirectorBrendon M. Dibella · Reston, VADirectorDaniel R. Chevallard · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗